0.4801
price down icon2.81%   -0.0139
 
loading
Precedente Chiudi:
$0.494
Aprire:
$0.47
Volume 24 ore:
255.24K
Relative Volume:
0.54
Capitalizzazione di mercato:
$21.47M
Reddito:
$106.79M
Utile/perdita netta:
$-8.73M
Rapporto P/E:
-2.4005
EPS:
-0.2
Flusso di cassa netto:
$10.81M
1 W Prestazione:
-12.71%
1M Prestazione:
-13.43%
6M Prestazione:
+8.72%
1 anno Prestazione:
-25.00%
Intervallo 1D:
Value
$0.459
$0.4906
Intervallo di 1 settimana:
Value
$0.40
$0.5422
Portata 52W:
Value
$0.2813
$0.9458

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name
Nome
Harvard Bioscience Inc
Name
Telefono
(508) 893-8999
Name
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Name
Dipendente
355
Name
Cinguettio
Name
Prossima data di guadagno
2026-03-12
Name
Ultimi documenti SEC
Name
HBIO's Discussions on Twitter

Compare HBIO vs ISRG, BDX, ALC, RMD, MDLN

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
HBIO
Harvard Bioscience Inc
0.48 22.09M 106.79M -8.73M 10.81M -0.20
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
472.78 170.20B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
160.26 45.41B 21.92B 1.76B 2.63B 6.1223
Medical Instruments & Supplies icon
ALC
Alcon Inc
77.01 38.26B 10.40B 980.00M 1.61B 1.9749
Medical Instruments & Supplies icon
RMD
Resmed Inc
231.56 33.86B 5.40B 1.49B 1.78B 10.12
Medical Instruments & Supplies icon
MDLN
Medline Inc
41.33 33.33B 28.43B 1.16B 1.26B 1.4457

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-09 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2023-03-10 Aggiornamento The Benchmark Company Speculative Buy → Buy
2021-01-07 Aggiornamento The Benchmark Company Speculative Buy → Buy
2020-12-09 Iniziato Northland Capital Outperform
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2019-07-08 Downgrade Janney Buy → Neutral
2018-01-24 Reiterato Janney Buy
2018-01-23 Reiterato The Benchmark Company Buy
2016-11-17 Iniziato Singular Research Buy
2015-07-28 Iniziato The Benchmark Company Buy
Mostra tutto

Harvard Bioscience Inc Borsa (HBIO) Ultime notizie

pulisher
10:35 AM

HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus

10:35 AM
pulisher
08:31 AM

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey

08:31 AM
pulisher
08:25 AM

Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView

08:25 AM
pulisher
08:11 AM

Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com

08:11 AM
pulisher
02:38 AM

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com

02:38 AM
pulisher
Mar 12, 2026

Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience: Q4 Earnings Snapshot - Chron

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience (HBIO) Earnings Transcript - AOL.com

Mar 12, 2026
pulisher
Mar 12, 2026

Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience Q4 & Annual Financial Results 2025News and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet

Mar 12, 2026
pulisher
Mar 12, 2026

Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com

Mar 12, 2026
pulisher
Mar 12, 2026

HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 12, 2026
pulisher
Mar 12, 2026

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph

Mar 12, 2026
pulisher
Mar 10, 2026

Harvard Bioscience promotes Frost to CFO - Worcester Business Journal

Mar 10, 2026
pulisher
Mar 10, 2026

Harvard Bioscience Amends Executive Employment Agreements for CEO John Duke and CFO Mark Frost – Key Terms and Provisions - Minichart

Mar 10, 2026
pulisher
Mar 10, 2026

Harvard Bioscience Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

Harvard Bioscience Updates Executive Contracts and Finance Leadership - TipRanks

Mar 10, 2026
pulisher
Mar 09, 2026

Harvard Bioscience Announces Reverse Stock Split - 富途牛牛

Mar 09, 2026
pulisher
Mar 08, 2026

Harvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight - Nasdaq

Mar 08, 2026
pulisher
Mar 07, 2026

Aug Volume: Can Harvard Bioscience Inc grow without external funding2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Harvard Bioscience executes 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria

Mar 07, 2026
pulisher
Mar 07, 2026

Bank Watch: Can Harvard Bioscience Inc navigate macro headwindsTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Harvard Bioscience executes 1-for-10 reverse stock split - Investing.com

Mar 06, 2026
pulisher
Mar 06, 2026

Bull Bear: Does Harvard Bioscience Inc offer margin of safetyJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience Approves Reverse Stock Split to Regain Compliance - TipRanks

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience Announces 1-for-10 Reverse Stock Split Effective March 13, 2026 - Quiver Quantitative

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience announces reverse stock split - marketscreener.com

Mar 06, 2026
pulisher
Mar 06, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 06, 2026
pulisher
Mar 06, 2026

Harvard Bioscience to turn 10 shares into 1 in March split - Stock Titan

Mar 06, 2026
pulisher
Mar 05, 2026

Harvard Bioscience (HBIO) to Release Quarterly Earnings on Thursday - Defense World

Mar 05, 2026
pulisher
Mar 04, 2026

Harvard Bioscience (NASDAQ:HBIO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Mar 04, 2026
pulisher
Mar 03, 2026

Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - The Manila Times

Mar 03, 2026
pulisher
Feb 26, 2026

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - ChartMill

Feb 26, 2026
pulisher
Feb 26, 2026

Aug Breakouts: Is Harvard Bioscience Inc stock trending bullishJuly 2025 Earnings & Real-Time Market Sentiment Reports - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 20, 2026

Is Harvard Bioscience Inc. a cyclical or defensive stockBond Market & Fast Gain Stock Tips - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Volume Report: Is Harvard Bioscience Inc exposed to political riskDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 15, 2026

What makes Harvard Bioscience Inc. stock attractive to growth fundsJuly 2025 Setups & Verified Trade Idea Suggestions - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Is Harvard Bioscience Inc. stock forming a triangle patternJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

How Harvard Bioscience Inc. stock reacts to Fed rate cutsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

HBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

HBIO Should I Buy - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

Is Harvard Bioscience Inc. forming a bullish divergenceWeekly Trade Analysis & High Accuracy Swing Trade Signals - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Why Harvard Bioscience Inc. stock could be next big winnerWeekly Profit Summary & Long Hold Capital Preservation Plans - mfd.ru

Feb 12, 2026

Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$66.72
price up icon 0.94%
$166.75
price down icon 0.01%
medical_instruments_supplies COO
$70.48
price down icon 1.46%
$75.27
price up icon 0.09%
medical_instruments_supplies WST
$235.93
price up icon 2.23%
$41.15
price up icon 0.44%
Capitalizzazione:     |  Volume (24 ore):